A Single-arm, Open-label Feasibility Study for Assessing the Safety and Performance of the Modified AssiAnchor
cataracts
1 other identifier
interventional
10
1 country
1
Brief Summary
The AssiAnchor 2 is a fixation ophthalmic device. The device is manufactured by Hanita Lenses from PMMA material which is being used for the production of Intra-ocular lenses. The device is intended for patients requiring capsule centration to clip the anterior lens capsule between the arms of the device and secure it to the scleral wall.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2018
CompletedFirst Posted
Study publicly available on registry
March 6, 2018
CompletedStudy Start
First participant enrolled
March 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2021
CompletedMarch 2, 2022
February 1, 2022
3.2 years
February 11, 2018
February 26, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Safety of the new AssiAnchor.
Stability of device with in the eye will be assessed
1 year
performance of the new AssiAnchor.
We will assess if implantation of AssiAnchor * Enables cataract surgery for subluxated lens * Centers subluxated capsule * Provides a wide contact between the device and the anterior capsule
1 year
Study Arms (1)
capsular fixation surgery
EXPERIMENTALpatients required capsule centration safely undergo capsular fixation surgery with AssiAnchor under local anesthesia .
Interventions
The novel device, the capsular "Anchor", was designed to secure the capsular bag to the scleral wall. The device is a one-piece, one-plane intraocular implant . It works like a paper clip; holding the anterior capsule between a central rod, placed in front of the capsule, and the two lateral arms, inserted through the eye surgery and placed behind the capsule.
Eligibility Criteria
You may qualify if:
- Requires capsule centration during or after cataract surgery.
- Understands the study requirements and the treatment procedures
- Sign Informed Consent before any study-specific tests or procedures.
You may not qualify if:
- Diagnosed with active anterior segment intraocular inflammation.
- Obligated to participation in another clinical study within the past 30 days.
- Pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hanita Lenseslead
Study Sites (1)
MeirMC
Kfar Saba, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2018
First Posted
March 6, 2018
Study Start
March 24, 2018
Primary Completion
June 9, 2021
Study Completion
June 9, 2021
Last Updated
March 2, 2022
Record last verified: 2022-02